MedPath

Prospective investigation of the relationship between plasma cardiac biomarkers(Neprilysin, pro BNP, ANP and BNP) and pathology of patients with chronic heart failure

Not Applicable
Conditions
heart failure
Registration Number
JPRN-UMIN000026209
Lead Sponsor
Cardiovascular Medicine Okayama University Graduate School of. Medicine, Dentistry and Pharmaceutical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
140
Inclusion Criteria

Not provided

Exclusion Criteria

(a)Patients received investigational new drugs within six months (b)Patients with non-cardiac or non-renal disease(such as a malignancy, serious infection, and so on) and their prognoses are less than one year (c)Patients with renal insufficiency (eGFR< 30 ml/min/1.73m2) or on maintenance dialysis (d)Patients who is not suitable to this study due to medical reasons

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
plasma cardiac biomarkers(Neprilysin, pro BNP, ANP and BNP)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath